Income Statement

v3.10.0.1
CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS - USD ($)
3 Months Ended
Jun. 30, 2018
Jun. 30, 2017
Operating expenses:    
Research and development $ 2,743,700 $ 1,096,200
General and administrative 1,466,300 1,164,300
Total operating expenses 4,210,000 2,260,500
Loss from operations (4,210,000) (2,260,500)
Other expenses, net:    
Interest expense, net (2,100) (2,400)
Loss before income taxes (4,212,100) (2,262,900)
Income taxes (2,400) (2,400)
Net loss and comprehensive loss (4,214,500) (2,265,300)
Accrued dividends on Series B Preferred stock (273,500) (247,300)
Net loss attributable to common stockholders $ (4,488,000) $ (2,512,600)
Basic and diluted net loss attributable to common stockholders per common share $ (0.20) $ (0.28)
Weighted average shares used in computing basic and diluted net loss attributable to common stockholders per common share 22,987,066 9,034,213

Source